Ye Xin Tao, Henmi Soichiro, Buratto Edward, Haverty Mitchell C, Yerebakan Can, Fricke Tyson, Brizard Christian P, d'Udekem Yves, Konstantinov Igor E
Department of Cardiac Surgery, Royal Children's Hospital, Melbourne, Victoria, Australia.
Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia.
JTCVS Open. 2024 Apr 11;19:241-256. doi: 10.1016/j.xjon.2024.04.003. eCollection 2024 Jun.
The optimal treatment strategy for symptomatic young infants with tetralogy of Fallot (TOF) is unclear. We sought to compare the outcomes of staged repair (SR) (shunt palliation followed by second-stage complete repair) versus primary repair (PR) at 2 institutions that have exclusively adopted each strategy.
We performed propensity score-matched comparison of 143 infants under 4 months of age who underwent shunt palliation at one institution between 1993 and 2021 with 122 infants who underwent PR between 2004 and 2018 at another institution. The primary outcome was mortality. Secondary outcomes were postoperative complications, durations of perioperative support and hospital stays, and reinterventions. Median follow-up was 8.3 years (interquartile range, 8.1-13.4 years).
After the initial procedure, hospital mortality (shunt, 2.8% vs PR, 2.5%; = .86) and 10-year survival (shunt, 95%; 95% confidence interval [CI], 90%-98% vs PR, 90%; 95% CI, 81%-95%; = .65) were similar. The SR group had a greater risk of early reinterventions but similar rates of late reinterventions. Propensity score matching yielded 57 well-balanced pairs. In the matched cohort, the SR group had similar freedom from reintervention (55%; 95% CI, 39%-68% vs 59%; 95% CI, 43%-71%; = .85) and greater survival (98%; 95% CI, 88%-99.8% vs 85%; 95% CI, 69%-93%; = .02) at 10 years, as the result of more noncardiac-related mortalities in the PR group.
In symptomatic young infants with TOF operated at 2 institutions with exclusive treatment protocols, the SR strategy was associated with similar cardiac-related mortality and reinterventions as the PR strategy at medium-term follow-up.
对于有症状的法洛四联症(TOF)幼儿,最佳治疗策略尚不清楚。我们试图比较在两个分别专门采用不同策略的机构中,分期修复(SR)(先行分流姑息治疗,随后进行二期完全修复)与一期修复(PR)的治疗结果。
我们对1993年至2021年间在一家机构接受分流姑息治疗的143例4个月以下婴儿与2004年至2018年间在另一家机构接受PR的122例婴儿进行倾向评分匹配比较。主要结局是死亡率。次要结局包括术后并发症、围手术期支持和住院时间以及再次干预情况。中位随访时间为8.3年(四分位间距,8.1 - 13.4年)。
初始手术后,医院死亡率(分流组为2.8%,PR组为2.5%;P = 0.86)和10年生存率(分流组为95%;95%置信区间[CI],90% - 98%,PR组为90%;95% CI,81% - 95%;P = 0.65)相似。SR组早期再次干预的风险更高,但晚期再次干预率相似。倾向评分匹配产生了57对平衡良好的配对。在匹配队列中,10年时SR组再次干预的自由度相似(55%;95% CI,39% - 68%对59%;95% CI,43% - 71%;P = 0.85),且生存率更高(98%;95% CI,88% - 99.8%对85%;95% CI,69% - 93%;P = 0.02),原因是PR组有更多非心脏相关死亡。
在两家采用独家治疗方案的机构中接受手术的有症状TOF幼儿,在中期随访时,SR策略与PR策略的心脏相关死亡率和再次干预情况相似。